
None
NoneHunter Biden gun case terminated after President Joe Biden's sweeping pardon
Best TV of 2024: A modestly better lineup than usual, but why didn’t it feel that way?NoneJupiter, Florida, Dec. 04, 2024 (GLOBE NEWSWIRE) -- Jupiter Neurosciences, Inc. (Nasdaq: JUNS) (the “Company” or “Jupiter Neurosciences”), a clinical stage pharmaceutical company advancing a pipeline targeting neuroinflammation with its unique resveratrol platform product, JOTROL TM , today announced the closing of its initial public offering of 2,750,000 shares of common stock at a price of $4.00 per share for gross proceeds of $11 million, before deducting underwriting discounts and other related expenses. The Company’s shares began trading on the Nasdaq Capital Market on December 3, 2024 under the symbol “JUNS.” The Company intends to use the net proceeds from the Offering to fund the Phase II clinical trial of its product candidate JOTROL TM in patients with Parkinson’s Disease, Strategic Service Agreements to accelerate business activities in South-East Asia, research and development activities regarding evaluation of new product opportunities, payment of the outstanding annual license fees due to Aquanova AG, the repayment of debt, working capital and other general corporate purposes. Dominari Securities LLC acted as the lead underwriter, with Revere Securities LLC acting as the co-manager for the offering. Anthony, Linder & Cacomanolis, PLLC acted as legal counsel to Jupiter Neurosciences and ArentFox Schiff LLP acted as legal counsel to the Underwriters in connection with the offering. The Company’s Registration Statement on Form S-1 (File No. 333- 260183) relating to the securities being offered was previously filed with, and subsequently declared effective by the U.S. Securities and Exchange Commission (the “SEC”) on November 8, 2024. The offering was made by means of a prospectus, forming part of the Registration Statement. You may get these documents for free by visiting EDGAR on the SEC website at www.sec.gov . Alternatively, copies of the prospectus relating to the offering may be obtained, when available, from Dominari Securities LLC by email at info@dominarisecurities.com , by standard mail to Dominari Securities LLC, 725 Fifth Avenue, 23rd Floor New York, NY 10022, or by telephone at (212) 393-4500; or from Revere Securities LLC by email at contact@reveresecurities.com , by standard mail to Revere Securities LLC, 560 Lexington Avenue, 16th Floor, New York, NY 10022, or by telephone at +1 (212) 688-2350. This press release has been prepared for informational purposes only and shall not constitute an offer to sell or the solicitation of an offer to buy any securities, and no sale of these securities may be made in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or other jurisdiction. About Jupiter Neurosciences, Inc. Jupiter Neurosciences, Inc. is a clinical-stage pharmaceutical company focused on treating neuroinflammation, with a current focus on CNS disorders and rare diseases. The Company’s platform product, JOTROL TM , is an enhanced orally administered resveratrol formulation designed and intended to deliver therapeutically relevant, safe levels of resveratrol. The Company’s pipeline is focused broadly on CNS disorder and includes indications such as Alzheimer’s Disease, Parkinson’s Disease, Mucopolysaccharidoses Type I, Friedreich’s Ataxia, and MELAS. More information may be found on the Company’s website www.jupiterneurosciences.com . FORWARD-LOOKING STATEMENTS Certain statements in this announcement are forward-looking statements. These forward-looking statements involve known and unknown risks and uncertainties and are based on the Company’s current expectations, including the use of proceeds from the Offering. Investors can find many (but not all) of these statements by the use of words such as “approximates,” “believes,” “hopes,” “expects,” “anticipates,” “estimates,” “projects,” “intends,” “plans,” “will,” “would,” “should,” “could,” “may” or other similar expressions. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct. The Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to read the risk factors contained in the Company’s final prospectus and other reports it files with the SEC before making any investment decisions regarding the Company’s securities. The Company undertakes no obligation to update or revise publicly any forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Contacts Investor Relations Alison Silva, President & CBO a.silva@jupiterneurosciences.com
LUQUE, Paraguay (AP) — Sake is perhaps more Japanese than the world-famous sushi. It's brewed in centuries-old mountaintop warehouses, savored in the country’s pub-like izakayas, poured during weddings and served slightly chilled for special toasts. Read this article for free: Already have an account? As we navigate through unprecedented times, our journalists are working harder than ever to bring you the latest local updates to keep you safe and informed. Now, more than ever, we need your support. Starting at $14.99 plus taxes every four weeks you can access your Brandon Sun online and full access to all content as it appears on our website. or call circulation directly at (204) 727-0527. Your pledge helps to ensure we provide the news that matters most to your community! LUQUE, Paraguay (AP) — Sake is perhaps more Japanese than the world-famous sushi. It's brewed in centuries-old mountaintop warehouses, savored in the country’s pub-like izakayas, poured during weddings and served slightly chilled for special toasts. Read unlimited articles for free today: Already have an account? LUQUE, Paraguay (AP) — Sake is perhaps more Japanese than the world-famous sushi. It’s brewed in centuries-old mountaintop warehouses, savored in the country’s pub-like izakayas, poured during weddings and served slightly chilled for special toasts. The smooth rice wine that plays a crucial role in Japan’s culinary traditions was enshrined on Wednesday by UNESCO on its list of the “intangible cultural heritage of humanity.” At a meeting in Luque, Paraguay, members of UNESCO’s committee for safeguarding humanity’s cultural heritage voted to recognize 45 cultural practices and products around the world, including Brazilian white cheese, Caribbean cassava bread and Palestinian olive oil soap. Unlike UNESCO’s World Heritage List, which includes sites considered important to humanity like the Pyramids of Giza in Egypt, the Intangible Cultural Heritage designation names products and practices of different cultures that are deserving of recognition. A Japanese delegation welcomed the announcement in Luque. “Sake is considered a divine gift and is essential for social and cultural events in Japan,” Kano Takehiro, the Japanese ambassador to UNESCO, told The Associated Press. The basic ingredients of sake are few: rice, water, yeast and koji, a rice mold, which breaks down the starches into fermentable sugars like malting does in beer production. The whole two-monthlong process of steaming, stirring, fermenting and pressing can be grueling. The rice — which wields tremendous marketing power as part of Japan’s broader cultural identity — is key to the alcoholic brew. For a product to be categorized Japanese sake, the rice must be Japanese. The UNESCO recognition, the delegation said, captured more than the craft knowledge of making high-quality sake. It also honored a tradition dating back some 1,000 years — sake makes a cameo in Japan’s famous 11th century novel, “The Tale of Genji,” as the drink of choice in the refined Heian court. Now, officials hope to restore sake’s image as Japan’s premier alcoholic drink even as the younger drinkers in the country switch to imported wine or domestic beer and whiskey. “It means a lot to Japan and to the Japanese,” Takehiro said of the UNESCO designation. “This will help to renew interest in traditional sake elaboration.” Also, Japanese breweries have expressed hope that the listing could give a little lift to the country’s export economy as the popularity of sake booms around the world and in the United States amid heightened interest in Japanese cuisine. Sake exports, mostly to the U.S. and China, now rake in over $265 million a year, according to the Japan Sake and Shochu Makers Association, a trade group. Japan’s delegation appeared ready to celebrate on Wednesday — in classic Japanese style. After the announcement, Takehiro raised a cypress box full of sake to toast the alcoholic brew and cultural rite. Advertisement
MINNEAPOLIS — Brian Thompson, the chief executive of Minnetonka-based UnitedHealthcare, has been shot and killed in Manhattan in what police officials called a brazen attack that apparently targeted the Maple Grove resident. Thompson, 50, was fatally shot outside the Hilton hotel in Midtown where video evidence indicates the gunman was “lying in wait” for several minutes and approached from behind, firing several rounds, said Jessica Tisch, commissioner of the New York Police Department, at a Wednesday news conference. The executive was struck at least once in the back and leg. “Brian Thompson, the CEO of UnitedHealthcare, was shot and killed in what appears — in this early stage of our investigation — to be a brazen, targeted attack,” Tisch said. “This does not appear to be a random act of violence.” The police commissioner added: “I want to be clear, at this time, every indication is that this was a premeditated, preplanned, targeted attack.” Police are offering a $10,000 reward for information on what they described as a homicide. They said the shooting occurred at about 6:40 a.m. Eastern time. Thompson was walking toward the hotel, police said, to attend the annual investor day conference for parent company UnitedHealth Group. The shooter arrived on the location about five minutes ahead of Thompson, who was walking alone without a security detail, said Chief of Detectives Joseph Kenny. Video shows the suspect step out from behind a car and ignore other pedestrians before shooting Thompson from behind, Kenny said. The suspect then walked toward Thompson and continued to shoot, until the gun apparently malfunctioned. After clearing the jam, the shooter began to fire again, Kenny said, and then fled on foot. Responding to reporter questions, Kenny said police don’t know if the shooter could have been a professional, nor could investigators say if there was a silencer on the weapon. From watching the video, he said, “it does seem that he’s proficient in the use of firearms as he was able to clear the malfunctions pretty quickly.” After his initial flight from the scene, the suspect was later seen riding an e-bike, including when he was spotted in Central Park. “The motive for this murder currently is unknown,” Kenny said. “Based on the evidence we have so far, it does appear that the victim was specifically targeted. But at this point, we do not know why.” Thompson was CEO of UnitedHealthcare, the nation’s largest health insurer. It is a division of Minnetonka-based UnitedHealth Group, which is the fourth-largest public company in America behind Walmart, Amazon and Apple. His wife, Paulette Reveiz Thompson, told NBC News that he had been receiving threats. “There had been some threats,” she said in a phone call to NBC News. “Basically, I don’t know, a lack of coverage? I don’t know details. I just know that he said there were some people that had been threatening him.” During the police news conference, reporters asked Kenny if there was any evidence to suggest a connection between the killing and a patient upset over insurance coverage. ”We’re looking at everything,” the chief of detectives said. “We’re looking at (Thompson’s) social media. We are interviewing employees. We are interviewing family members. We will be speaking to law enforcement in Minnesota.” Thompson arrived in New York on Monday, Kenny said. Police had begun the process to search Thompson’s hotel room, he said, adding: “We’re reaching out to law enforcement in Minnesota and we’re also interviewing his co-workers and family members to see if there have been any specific threats against him in the past.” Thompson was named chief executive of the insurance division in April 2021. For several years prior, he ran the Medicare Advantage business within UnitedHealthcare, which has been at the center of recent industry scrutiny over risk adjustment payments and prior authorization denials . Company leaders were gathered at the annual conference for parent company UnitedHealth Group when CEO Andrew Witty abruptly halted the meeting just after 9 a.m. Eastern time. “We’re dealing with a very serious medical situation with one of our team members,” Witty said. “As a result, I’m afraid, we’re going to have to bring to a close the event.” Thompson’s two sons are Wayzata High School students, one current and one who graduated this past spring. His elder son lettered three years on the lacrosse team, said one of his coaches. His parents “were present around all of the team events,” said assistant coach Brandon Carlson, who saw breaking news reports of Brian Thompson’s death but had not realized it was the father of his former athlete. Brian and Paulette Thompson “were very supportive of their son,” Carlson said. “He’s an amazing young man and a teammate everyone would want to have.” His second son is a sophomore and active on the track and field team. Wayzata High School Principal Scott Gengler sent a note to staff Wednesday morning expressing deep sympathies to the family. “Wayzata High School has taken immediate steps to support our students and staff as they process this devastating event,” Gengler wrote in a memo shared with the Star Tribune. Thompson was an executive with the company for two decades. He graduated in 1997 from the University of Iowa, where he studied business administration and accounting, according to a LinkedIn page . “He was humble, a servant-leader and family man,” said John Penshorn, a former UnitedHealth Group executive who worked with Thompson for more than a decade before retiring in 2019. Steve Parente, a health economist at the University of Minnesota and former health care official in the Trump administration, said he worked with Thompson to help create a system for distributing federal financial aid to health care providers during the early days of the COVID-19 pandemic. ”He was just an incredible guy — nice, resourceful,” said Parente, who worked in the White House at the time. “This is just a total tragedy.” Several prominent Minnesotans took to social media Wednesday morning to express their condolences over the loss. Minnesota Gov. Tim Walz said on social media : “This is horrifying news and a terrible loss for the business and health care community in Minnesota. Minnesota is sending our prayers to Brian’s family and the UnitedHealthcare team.” Sen. Amy Klobuchar said , “This is a horrifying and shocking act of violence. My thoughts are with Brian Thompson’s family and loved ones and all those working at UnitedHealthcare in Minnesota.” The scene at UnitedHealthcare’s headquarters in Minnetonka was somber Wednesday. Snow squalls battered the U.S., Minnesota and company flags flying at half-staff as television news crews filmed. A bouquet of flowers lay inside the building’s front entrance. Several Minnetonka police cars camped outside the campus, and the department appeared to position a security tower to monitor the headquarters. A spokesperson for the Minnetonka Police Department said it’s proactively stepping up patrols in the area of UnitedHealthcare’s campus and has been in touch with the company’s security team. The spokesperson was not aware of any specific threats targeting the campus. Police records show there have been many calls from company headquarters since January 2021, but a substantial number of those were 911 hangups. On July 15, 11 people were arrested when the People’s Action Institute staged a protest over the company’s allegedly improper refusals to authorize or pay for care. UnitedHealth Group said at the time the safety of its workers was a top priority, and it had resolved the group’s specific concerns, remaining open to a broader dialogue on access to care matters. Other calls have included three for an “unwanted person” and one each for an alleged threat, a civil matter and a disturbance. The civil matter involved a UnitedHealthcare client living in California who was in a reimbursement dispute in May involving $1,000. Following Thompson’s shooting, UnitedHealth Group issued a statement saying the company was working closely with the New York Police Department. “We are deeply saddened and shocked at the passing of our dear friend and colleague,” the company said. “Brian was a highly respected colleague and friend to all who worked with him. ... Our hearts go out to Brian’s family and all who were close to him.” (Minnesota Star Tribune reporters Victor Stefanescu and Paul Walsh contributed to this report.) ©2024 The Minnesota Star Tribune. Visit startribune.com . Distributed by Tribune Content Agency, LLCIs New Year’s Eve all hype or the best party ever? Lewiston residents weigh in.